Genzyme could be off the block

<strong>CAMBRIDGE.</strong> Cambridge drug company Genzyme Corp. will likely be bought by a French company.

CAMBRIDGE. Cambridge drug company Genzyme Corp. will likely be bought by a French company. Yesterday, Sanofi-Aventis SA put in a $18.5 billion public bid for Genzyme, a move that was rumored to be in the works for months. Genzyme shareholders would receive $69 per share.

 
 
Latest From ...
Most Popular From ...